481 related articles for article (PubMed ID: 26811624)
1. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic targets for pancreatic cancer.
Tang SC; Chen YC
World J Gastroenterol; 2014 Aug; 20(31):10825-44. PubMed ID: 25152585
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
[TBL] [Abstract][Full Text] [Related]
4. New targeted therapies in pancreatic cancer.
Seicean A; Petrusel L; Seicean R
World J Gastroenterol; 2015 May; 21(20):6127-45. PubMed ID: 26034349
[TBL] [Abstract][Full Text] [Related]
5. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
6. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
7. Companion diagnostics for the targeted therapy of gastric cancer.
Yoo C; Park YS
World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
Pishvaian MJ; Brody JR
Oncology (Williston Park); 2017 Mar; 31(3):159-66, 168. PubMed ID: 28299752
[TBL] [Abstract][Full Text] [Related]
9. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
10. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.
Sahin IH; Lowery MA; Stadler ZK; Salo-Mullen E; Iacobuzio-Donahue CA; Kelsen DP; O'Reilly EM
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):893-905. PubMed ID: 26881472
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential.
Camilli M; Papadimitriou K; Nogueira A; Incorvaia L; Galvano A; D'Antonio F; Ferri J; Santini D; Silvestris N; Russo A; Peeters M; Rolfo C
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):471-478. PubMed ID: 29629846
[TBL] [Abstract][Full Text] [Related]
12. Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
Yee NS
Adv Exp Med Biol; 2013; 779():91-143. PubMed ID: 23288637
[TBL] [Abstract][Full Text] [Related]
13. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.
Onishi H; Katano M
World J Gastroenterol; 2014 Mar; 20(9):2335-42. PubMed ID: 24605030
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy in esophageal cancer.
Zhang L; Ma J; Han Y; Liu J; Zhou W; Hong L; Fan D
Expert Rev Gastroenterol Hepatol; 2016; 10(5):595-604. PubMed ID: 26895097
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy.
Donadelli M; Dando I; Dalla Pozza E; Palmieri M
World J Gastroenterol; 2015 Mar; 21(11):3232-8. PubMed ID: 25805929
[TBL] [Abstract][Full Text] [Related]
17. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cell targeted therapy: progress amid controversies.
Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.
Birnbaum DJ; Bertucci F; Finetti P; Birnbaum D; Mamessier E
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):248-255. PubMed ID: 29499330
[TBL] [Abstract][Full Text] [Related]
20. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]